Bethesda, MD The FDA Cardiovascular and Renal Drugs Advisory Committee has voted unanimously to grant AstraZeneca LP the right to claim superiority of once-a-day dosing with candesartan cilexetil ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback